Dirk Thye - 28 Jan 2025 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
CEO AND CHIEF MEDICAL OFFICER, Director
Signature
/s/ Dirk Thye
Issuer symbol
QNCX
Transactions as of
28 Jan 2025
Net transactions value
$0
Form type
4
Filing time
11 Feb 2025, 17:44:38 UTC
Previous filing
03 Sep 2024
Next filing
23 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Employee Stock Option (right to buy) Award $0 +1,200,000 $0.000000 1,200,000 28 Jan 2025 Common Stock 1,200,000 $1.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2025, such that the total number of shares shall be fully vested on the four-year anniversary of the vesting commencement date.